Corvus Pharmaceuticals, Inc. CRVS

CRVS

Corvus Pharmaceuticals, Inc.

Exchange: nyse

Multiples

P/E: -5.88
P/BV: 6.59
P/TBV: 8.64

Description:

none

Data:

Market Cap

334137952.00

EBITDA

Net Income

Yields:

Earnings Yield

Return on Capital

CAGR (net income)

0%

CAGR Length

0

Dividend Rate